ArticleBMJ paediatrics open2026
Mortality and morbidity in very preterm infants in Switzerland spanning 16 years (2006-2021).
Article in BMJ paediatrics open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo report population-based gestational age (GA) stratified mortality and morbidity for very preterm infants spanning 16 years in Switzerland.
designSwiss population-based study with prospectively collected data for infants born at less than 32 weeks GA, spanning three time periods: 2006-2011 (P1), 2012-2016 (P2), 2017-2021 (P3).
settingThe Swiss Neonatal Network, covering all Level III neonatal intensive care units (NICUs) and affiliated paediatric hospitals. POPULATION: Preterm live-born infants (12 453) less than 32 weeks GA.
main outcome measuresTrends in GA-related mortality, survival without major complications and short-term morbidities among very preterm infants in Switzerland.
resultsOverall survival increased significantly from 85.4% in P1 to 89.7% in P3 (p<0.01), with greatest gains among infants born before 26 weeks GA. Delivery room and NICU mortality declined significantly, from 6.0% to 4.1% and from 8.6% to 6.2%, respectively.Survival without major complications-such as bronchopulmonary dysplasia (BPD), intraventricular haemorrhage (IVH), necrotising enterocolitis (NEC), retinopathy of prematurity (ROP) and cystic periventricular leukomalacia (cPVL)-remained stable (around 72%). Major morbidities occurred in 17.3% of survivors.Among survivors, BPD and ROP significantly increased across periods while NEC increased only in infants born at 25 weeks GA. Conversely, cPVL declined over time.
conclusionsThe survival rate of very preterm infants in Switzerland increased from 2006 to 2021, especially in those born before 26 weeks GA. Survival without major comorbidities among infants born at 23-31 weeks remained unchanged. In survivors, BPD and ROP increased over time; NEC increased only in 25-week infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.